NCT06607666View on ClinicalTrials.gov

Acromegaly Resistant to Conventional Dose of First Generation Somatostatin Ligands

CompletedOBSERVATIONAL
Enrollment

102

Participants

Timeline

Start Date

January 26, 2023

Primary Completion Date

January 31, 2024

Study Completion Date

July 31, 2024

Conditions
Acromegaly
Interventions
DRUG

Lanreotide autogel

Identification of clinical, biochemical, molecular markers of response to low and high dose of fg-SRLs

Trial Locations (1)

00168

Fondazione Policlinico Universitario Agostino Gemelli IRCCS, UOC ENDOCRINOLOGIA, Roma

All Listed Sponsors
lead

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

OTHER